We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Lou Gehrig's disease

News List

Organs-on-chip technology reveals new drug candidates for Lou Gehrig's disease worldpharmanews
October 12, 2018
The investigation of amyotrophic lateral sclerosis (ALS) - also known as Lou Gehrig's disease - through muscle-on-a-chip technology has revealed a new drug combination that may serve as an effective treatment of the progressive neurodegenerative disease.
Organs-on-chip technology reveals new drug candidates for Lou Gehrig's disease worldpharmanews
October 12, 2018
The investigation of amyotrophic lateral sclerosis (ALS) - also known as Lou Gehrig's disease - through muscle-on-a-chip technology has revealed a new drug combination that may serve as an effective treatment of the progressive neurodegenerative disease.
First FDA-Approved Treatment for ALS in 22 Years Now Available In U.S. americanpharmaceuticalreview
August 09, 2017
Mitsubishi Tanabe Pharma America announced RADICAVA (edaravone) is now available for treatment in the United States.